Results 121 to 130 of about 1,671,881 (203)

Sulfometuron-Methyl Disrupts Early Zebrafish Embryonic Development via Wnt/β-Catenin Signaling Pathway. [PDF]

Toxics
Zhang X, Liu J, Guo Y, Zhong J, Dong Y, Cheng S, Li Z, Qiang W, Wang H.   +8 more
europepmc   +1 more source

The NLRP3 Inflammasome: Mechanisms of Activation, Regulation, and Therapeutic Opportunities. [PDF]

MedComm (2020)
Zou C, Jiang S, Li H, Zhao K, Cao D, Yang G.   +5 more
europepmc   +1 more source

The Development of Anti-Tumor Activity of Sulfonylurea Compounds

Hans Journal of Medicinal Chemistry, 2015
openaire   +1 more source

Glycemic Control and Utilization Risk With the Conversion of Glimepiride to Glipizide in Adults 64 Years and Older at an Integrated Health Care System. [PDF]

J Am Geriatr Soc
Lee EA, Lin JC, Kanter MH, Hsieh TI, Martin JP, Silverman JS, Yoshinaga MA, Chiu G, Asrat MF, Kohanim SY, Broder BI.   +10 more
europepmc   +1 more source

Genetic and Clinical Determinants of Variation in Drug Response in Type 2 Diabetes: Insights From the Scottish and UK Biobank Cohorts. [PDF]

Diabetes Obes Metab
Garg S, Kitchen R, Gupta R, Donnelly L, Pearson ER.   +4 more
europepmc   +1 more source

PERsonalised Medicine for Intensification of Treatment (PERMIT) in type 2 diabetes mellitus: a target trial emulation from routine data.

Health Technol Assess
Lugo-Palacios DG, Bidulka P, Charlton P, Huston B, Carnegie A, Carroll O, O'Neill S, Adler AI, Basu A, Silverwood RJ, Briggs AH, Smeeth L, Douglas IJ, Khunti K, Grieve R.   +14 more
europepmc   +1 more source

Controllable Ion-Repulsion Enables Rapid and Trace-Level Detection of Hydrophobic Sulfonylurea Herbicides with ICPMS/MS without the Organic Mode. [PDF]

Anal Chem
Lajin B, Goessler W.
europepmc   +1 more source

Real-world effectiveness of quadruple oral hypoglycemic therapy in type 2 diabetes patients refusing insulin therapy. [PDF]

BMC Endocr Disord
Baek HS, Jeong C, Sohn TS, Son HS.
europepmc   +1 more source

[Case of hypersensitivity to sulfonylurea compounds].

Wiadomosci lekarskie (Warsaw, Poland : 1960), 1983
openaire   +1 more source

Glucagon-like Peptide-1 Receptor Agonists and Risk of Tuberculosis in Type 2 Diabetes. [PDF]

Nat Commun
Liao KM, Wu JY, Lai CC.
europepmc   +1 more source